1. Speroff L, Fritz MA. Clinical gynecologic endocrinology and infertility 2005;7th ed. Baltimore: Lippincott Williams & Wilkins. 549.
2. Haynes PJ, Hodgson H, Anderson AB, Turnbull AC. Measurement of menstrual blood loss in patients complaining of menorrhagia. Br J Obstet Gynaecol 1977;84:763.
3. Goodman A. Abnormal genital tract bleeding. Clin Cornerstone 2000;3:25-35.
4. American Medical Association. Diagnostic and treatment guidelines on child sexual abuse 1992;Chicago: American Medical Association.
5. Herman-Giddens ME. Vaginal foreign bodies and child sexual abuse. Arch Pediatr Adolesc Med 1994;148:195-200.
6. Anveden-Hertzberg L, Gauderer MW, Elder JS. Urethral prolapse: an often misdiagnosed cause of urogenital bleeding in girls. Pediatr Emerg Care 1995;11:212-214.
7. Herman-Giddens MF, Slora EJ, Wasserman RC. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics 1997;99:505-512.
8. World Health Organization Task Force on Adolescent Reproductive Health. Longitudinal study of menstrual patterns in the early postmenarchal period, duration of bleeding episodes and menstrual cycles. J Adolesc Health Care 1986;7:236-244.
9. Slap GB. Menstrual disorders in adolescence. Best Pract Res Clin Obstet Gynaecol 2003;17:75-92.
10. Burke AE, Blumenthal PD. Successful use of oral contraceptives. Semin Reprod Med 2001;19:313-321.
11. Rosenberg MJ, Burnhill MS, Waugh MS. Compliance and oral contraceptives: a review. Contraception 1995;52:137-141.
12. Oakley D, Sereika S, Bogue EL. Oral contraceptive pill use after an initial visit to a family planning clinic. Fam Plann Perspect 1991;23:150-154.
13. Balassone ML. Risk of oral contraceptive discontinuation among adolescents. J Adolesc Health Care 1989;10:527-533.
14. Clawssens EA, Cowell CA. Acute adolescent menorrhagia. Am J Obstet Gynecol 1981;139:277-280.
15. Centers for Disease Control And Prevention. 1998 guidelines for treatment of sexually transmitted diseases. MMWR Recomm Rep 1998;47:1-111.
16. Stewart EA, Nowak RA. Leiomyoma related bleeding: a classic hypothesis updated for the molecular era. Hum Reprod Update 1996;2:295-306.
17. Prentice A. In: Smith SK, editor. Healthcare implications of dysfunctional uterine bleeding London: Bailiere Tindall. 181-188.
18. Van Eijkeren MA, Christiaens GCML, Sixma JJ. Menorrhagia: a review. Obstet Gynecol Surv 1989;4:421-429.
19. Hoffman GE, Rao CV, DeLeon FD. Human endometrial prostaglandin E2 binding sites and their profiles during the menstrual cycle and in pathological states. Am J Obstet Gynecol 1985;151:369-375.
20. Smith SK, Abel MH, Kelly RW, Baird DT. Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. Br J Obstet Gynaecol 1981;88:434-442.
21. Makarainen L, Ylikorala O. Primary and myoma associated menorrhagia: role of prostaglandins and effects of ibuprofen. Br J Obstet Gynaecol 1986;93:974-978.
22. Cameron IT, Campbell S. Nitric oxide in the endometrium. Hum Reprod Update 1998;4:565-569.
23. Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding (Cochrane Review). The Cochrane Library 2002;vol. 4:Oxford: Update Software.
24. Lindoff C, Rybo G, Astedt B. Treatment with tranexamic acid during pregnancy, and the risk of thrombo-embolic complications. Thromb Haemost 1993;70:238-240.
25. Lethaby A, Augood C, Duckitt K. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding (Cochrane Review). The Cochrane Library vol. 4:Oxford: Update Software 2002.
26. Iyer V, Farquhar C, Jepson R. Oral contraceptive pills for heavy menstrual bleeding (Cochrane Review). The Cochrane Library 2002;vol. 4:Oxford: Update Software.
27. French RS, Cowan FM, Mansour D, Higgins JPT, Robinson A, Procter T, et al. Levonorgestrel-releasing (20 microgram/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptives. BJOG 2000;107:1218-1225.
28. Lethaby AE, Cooke I, Rees M. Progesterone/progestogen releasing intrauterine systems for heavy menstrual bleeding (Cochrane Review). The Cochrane Library 2002;vol.4:Oxford: Update Software.
29. Lethaby A, Hickey M, Garry R. Endometrial destruction techniques for heavy menstrual bleeding (Cochrane Review). The Cochrane Library 2006;Issue 3.
30. Malcolm G, Munro . Abnormal uterine bleeding: surgical management-part III. J Am Assoc Gynecol Laparosc 2001;8:18-44.
31. Munro Malcolm G. Abnormal uterine bleeding in the reproductive years: medical management-part III. J Am Assoc Gynecol Laparosc 2000;7:19-32.
32. Munro Malcolm G. Dysfunctional uterine bleeding: advances in diagnosis and treatment. Curr Opin Obstet Gynecol 2001;13:475-489.
33. Berek JS. Novak's Gynecology 2002;13th ed. Philadelphia: Lippincott Williams & Wilkins. 371.
34. Goldstein SR. Menorrhagia and before the menopause. Best Practice & Research Clinical Obstetrics 2004;181:59-69.
35. Moodley M, Roberts C. Clinical pathway for the evaluation of postmenopausal bleeding with an emphasis on endometrial cancer detection. J Obstet Gynaecol 2004;24:736-741.